4 июня в Бостоне начинается форум BIO-2018, одно из главных мировых событий в области биоиндустрии. В составе делегации Фонда «Сколково» во главе со старшим вице-президентом по инновациям Кириллом Каемом на BIO отправятся более 20 резидентов. Это...
Skolkovo resident startup ExoAtlet , which makes rehabilitation exoskeletons that help disabled people to walk again, has raised $5 million in investment to expand its business to Europe and beyond. The funding is being provided by the Korean company Cosmo...
Four Skolkovo biomed startups have obtained sponsorship from Johnson & Johnson, and met with the U.S. multinational’s executive vice president and chief scientific officer Paul Stoffels during his recent visit to the innovation centre. Skolkovo...
Every spring for the last three years, Russia’s leading space experts have met for the InSpace Forum in Moscow to discuss how to boost the country’s space industry by facilitating cooperation between the state space corporation Roscosmos and the...
When tech startups are being considered for resident status at the Skolkovo innovation centre, one of the conditions for acceptance is that their product or service must have potential for export. Skolkovo’s mission is not import substitution; on the...
It’s a big year for Promobot , a resident startup of the Skolkovo Foundation’s IT cluster. The Perm-based company has just released version 4 of its cheeky service robots, whose antics have made headlines around the world and which are already on...
На завершившейся в Лас-Вегасе выставке потребительской электроники было весьма заметно присутствие компаний из Фонда «Сколково». Некоторые из них выбрали площадку CES-2018 местом премьеры своих разработок Так, компания « Промобот »...
How does a country produce new generations of engineers equipped with the skills that are in demand in the real world once they graduate from university? Nearly two decades ago, a group of engineering schools set about tackling the widening gap between engineering...
OncoTartis Inc., the U.S. daughter company of Skolkovo resident biomed startup OncoTartis , has raised $6 million in investment to develop its treatment for acute myeloid leukaemia. The acute myeloid leukaemia drug is being developed simultaneously in...
Биотехнологическая компания OncoTartis Inc. (американская «дочка» резидента «Сколково» «Онкотартис») привлекла $6 млн на разработку препарата для лечения острых лейкозов. В компанию вложились Norma Investments Романа Абрамовича...
В американском сериале Silicon Valley один из персонажей в шутку говорит, что, когда стартап презентует себя на питч-сессии, обязательно звучит фраза: «Моя технология сделает мир лучше». В каждой шутке есть доля шутки, но реальная практика стартапов...
Russia’s official position on the potentially lucrative field of asteroid mining is that it is outlawed by the 1967 Outer Space Treaty, which declares that space is “the province of mankind,” and that its use and exploration must “benefit...
Gifted schoolchildren from the Urals cities of Perm and Yekaterinburg visited the Skolkovo innovation city on Friday to see some of the technologies being developed here and to learn about a new scholarship being launched for Russian students to study at the...
The occasions when it’s justifiable to trot out the well-worn opening lines of Leo Tolstoy’s “Anna Karenina” (“All happy families are alike; each unhappy family is unhappy in its own way”) are few and far between, but their...